CervoMed, Inc. (CRVO)
4.63
-0.60
(-11.47%)
USD |
NASDAQ |
Feb 20, 16:00
4.72
+0.09
(+1.94%)
After-Hours: 20:00
CervoMed EPS Diluted (Quarterly) : -0.8351 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.727M |
| Revenue (Quarterly) | 0.3226M |
| Total Expenses (Quarterly) | 8.049M |
| Enterprise Value | 15.55M |
| Profit Margin (Quarterly) | -2.40K% |
| Earnings Yield | -62.54% |
| Normalized Earnings Yield | -62.54 |